1. Home
  2. SLS vs TWIN Comparison

SLS vs TWIN Comparison

Compare SLS & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • TWIN
  • Stock Information
  • Founded
  • SLS 2012
  • TWIN 1918
  • Country
  • SLS United States
  • TWIN United States
  • Employees
  • SLS N/A
  • TWIN N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • TWIN Industrial Machinery/Components
  • Sector
  • SLS Health Care
  • TWIN Industrials
  • Exchange
  • SLS Nasdaq
  • TWIN Nasdaq
  • Market Cap
  • SLS 185.3M
  • TWIN 186.2M
  • IPO Year
  • SLS N/A
  • TWIN N/A
  • Fundamental
  • Price
  • SLS $1.85
  • TWIN $13.18
  • Analyst Decision
  • SLS Strong Buy
  • TWIN Strong Buy
  • Analyst Count
  • SLS 1
  • TWIN 1
  • Target Price
  • SLS $7.00
  • TWIN $12.00
  • AVG Volume (30 Days)
  • SLS 1.9M
  • TWIN 68.2K
  • Earning Date
  • SLS 11-12-2025
  • TWIN 11-05-2025
  • Dividend Yield
  • SLS N/A
  • TWIN 1.21%
  • EPS Growth
  • SLS N/A
  • TWIN N/A
  • EPS
  • SLS N/A
  • TWIN N/A
  • Revenue
  • SLS N/A
  • TWIN $340,738,000.00
  • Revenue This Year
  • SLS N/A
  • TWIN $10.79
  • Revenue Next Year
  • SLS N/A
  • TWIN $8.43
  • P/E Ratio
  • SLS N/A
  • TWIN N/A
  • Revenue Growth
  • SLS N/A
  • TWIN 15.46
  • 52 Week Low
  • SLS $0.77
  • TWIN $6.16
  • 52 Week High
  • SLS $2.27
  • TWIN $13.80
  • Technical
  • Relative Strength Index (RSI)
  • SLS 52.67
  • TWIN 69.93
  • Support Level
  • SLS $1.69
  • TWIN $12.79
  • Resistance Level
  • SLS $2.01
  • TWIN $13.80
  • Average True Range (ATR)
  • SLS 0.11
  • TWIN 0.68
  • MACD
  • SLS 0.00
  • TWIN 0.03
  • Stochastic Oscillator
  • SLS 50.00
  • TWIN 80.25

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: